61 results on '"Ferrarini, Marina"'
Search Results
2. Supplementary Figure Legends from Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma Patients
3. Data from Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma Patients
4. Supplementary Figures S1-S5 from Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma Patients
5. Supplementary Tables S1-S4 from Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma Patients
6. Supplementary Methods from Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma Patients
7. Data from Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma Patients
8. Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production
9. 26. CD95-induced calcium release and apoptosis are regulated by nitric oxide via a cGMP dependent pathway in human γδ T-lymphocytes
10. Protocol for generation of 3D bone marrow surrogate microenvironments in a rotary cell culture system
11. 3D-Dynamic Culture Models of Multiple Myeloma
12. 3D Models as a Tool to Assess the Anti-Tumor Efficacy of Therapeutic Antibodies: Advantages and Limitations
13. Immunometabolic activation of macrophages leads to cytokine production in the pathogenesis of KRAS-mutated histiocytosis
14. Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease
15. A Novel Histiocytosis With Synovial and Skin Involvement
16. Innovative Models to Assess Multiple Myeloma Biology and the Impact of Drugs
17. miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediators
18. Erdheim-Chester disease: An in vivo human model of Mϕ activation at the crossroad between chronic inflammation and cancer
19. 3D culture of Erdheim-Chester disease tissues unveils histiocyte metabolism as a new therapeutic target
20. The fibrogenic chemokine CCL18 is associated with disease severity in Erdheim-Chester disease
21. Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3D surrogate microenvironment
22. Tocilizumab in patients with multisystem Erdheim–Chester disease
23. Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim–Chester disease
24. HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment
25. Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma Patients
26. Angiopoietin-2 in Bone Marrow milieu promotes Multiple Myeloma-associated angiogenesis
27. CD95-induced calcium release and apoptosis are regulated by nitric oxide via a cGMP-dependent pathway in human γδ T-lymphocytes
28. Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease
29. BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease
30. Correction: Ex-Vivo Dynamic 3-D Culture of Human Tissues in the RCCS™ Bioreactor Allows the Study of Multiple Myeloma Biology and Response to Therapy
31. Ex-Vivo Dynamic 3-D Culture of Human Tissues in the RCCS™ Bioreactor Allows the Study of Multiple Myeloma Biology and Response to Therapy
32. Tumor Necrosis Factor α As a Master Regulator of Inflammation in Erdheim-Chester Disease: Rationale for the Treatment of Patients With Infliximab
33. A matter of life and death: More members of the TNF receptor family join human γδ T lymphocytes
34. Bortezomib induces autophagic death in proliferating human endothelial cells
35. NF-κB Modulates Sensitivity to Apoptosis, Proinflammatory and Migratory Potential in Short- versus Long-Term Cultured Human γδ Lymphocytes
36. Constitutive expression of IL-12Rβ2 on human multiple myeloma cells delineates a novel therapeutic target
37. Redox homeostasis modulates the sensitivity of myeloma cells to bortezomib
38. Hypoxia-inducible transcription factor–1 alpha determines sensitivity of endothelial cells to the proteosome inhibitor bortezomib
39. Immunohistochemical evidence of a cytokine and chemokine network in three patients with Erdheim-Chester disease: Implications for pathogenesis
40. MICA Expressed by Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance Plasma Cells Costimulates Pamidronate-Activated γδ Lymphocytes
41. A Relapsing Inflammatory Syndrome and Active Human Herpesvirus 8 Infection
42. Inherited Perforin and Fas Mutations in a Patient with Autoimmune Lymphoproliferative Syndrome and Lymphoma.
43. Inherited Perforin andFasMutations in a Patient with Autoimmune Lymphoproliferative Syndrome and Lymphoma
44. CD30 ligation differentially affects CXCR4-dependent HIV-1 replication and soluble CD30 secretion in non-Hodgkin cell lines and inγ δ T lymphocytes
45. Macrophages exposed to Mycobacterium tuberculosis release chemokines able to recruit selected leucocyte subpopulations: focus on gammadelta cells
46. Double-edged effect of Vγ9/Vδ2 T lymphocytes on viral expression in an in vitro model of HIV-1/mycobacteria co-infection
47. Skewing of cytotoxic activity and chemokine production, but not of chemokine receptor expression, in human type-1/-2 γ δ T lymphocytes
48. Human γδ T cells: a nonredundant system in the immune-surveillance against cancer
49. Engagement of CD30 shapes the secretion of cytokines by human γ δ T cells
50. Engagement of CD30 shapes the secretion of cytokines by human γ δ T cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.